OKLO

Oklo Inc. 10-Q Summary: Q2 2025

Business Context and Reporting Period

This report covers the quarterly period ended June 30, 2025. Oklo Inc. is an emerging growth company developing advanced fission power plants ("Aurora powerhouses") and nuclear fuel recycling technology. The company operates in a single reportable segment focused on research and development, commercialization of powerhouses, and radioisotope production following the acquisition of Atomic Alchemy, Inc. in February 2025.

Key Financial Metrics

Note: All figures in millions unless otherwise noted. The company has no revenue as it is pre-commercial.

Material Changes vs. Prior Period

• Capital Raise: In June 2025, Oklo completed a public offering of 7.67 million shares, raising net proceeds of approximately $441.6 million. This significantly increased total liquidity from $275.3 million at year-end 2024 to $683.0 million.
• Acquisition: On February 28, 2025, Oklo acquired Atomic Alchemy, Inc. for a total consideration of $28.4 million (cash and stock) to expand its radioisotope business. This resulted in the recognition of $27.5 million in indefinite-lived intangible assets (IPR&D) and $6.7 million in goodwill.
• Expense Growth: Operating expenses increased significantly year-over-year. For the six months ended June 30, 2025, General and Administrative (G&A) expenses rose 146.9% to $26.6 million, and Research and Development (R&D) expenses rose 34.3% to $19.3 million. This was driven by increased headcount, stock-based compensation, and professional fees related to the public offering and acquisition.
• Interest Income: Interest and dividend income surged 299.2% year-over-year to $7.4 million for the six-month period, reflecting higher cash balances and marketable securities.
• SAFE Conversion: Unlike the prior year, there were no losses from the change in fair value of Simple Agreements for Future Equity (SAFEs) in 2025, as all SAFEs were converted during the 2024 recapitalization.

Guidance, Outlook, and Risks

• Outlook: Management expects total net cash used in operating activities for the full year 2025 to range between $65.0 million and $80.0 million. The company believes its current liquidity is sufficient to fund operations for at least the next 12 months.
• Deployment Timeline: The first commercial Aurora powerhouse is targeted for completion in late 2027 or early 2028. The company has selected Kiewit as the lead constructor for the Idaho facility.
• Regulatory Progress: Oklo completed a Phase I pre-application readiness assessment with the NRC in July 2025 with no significant gaps identified. The company secured a site use permit from the DOE for the Idaho National Laboratory.
• Risks:
  • Regulatory Uncertainty: Success depends on obtaining NRC licenses for design, construction, and operation, which is uncertain and could be delayed.
  • Supply Chain: Potential disruptions due to trade policies, tariffs, and inflation could increase costs and delay deployment.
  • Internal Controls: Management concluded that disclosure controls and procedures were not effective as of June 30, 2025, due to a material weakness related to infrequent and complex transactions. Remediation is expected by December 31, 2025.
  • EGC Status: The company will lose Emerging Growth Company status effective December 31, 2025.

Investor Verification Checklist

• Verify the timeline and cost estimates for the first Aurora powerhouse deployment (targeted late 2027/early 2028).
• Monitor the progress of the NRC Combined License Application and the remediation of the material weakness in internal controls.
• Assess the commercial viability and revenue potential of the Atomic Alchemy radioisotope business (Abundantia and Meitner projects).
• Review the status of Power Purchase Agreements (PPAs) and the conversion of non-binding letters of intent into binding contracts.
• Track the burn rate against the $65M-$80M annual cash usage guidance to ensure liquidity sufficiency.